Cargando…

Berberine containing quadruple therapy for initial Helicobacter pylori eradication: An open-label randomized phase IV trial

BACKGROUND: Due to increasing antimicrobial resistance, a bismuth-based quadruple regimen has been recommended as an alternative first-line therapy for Helicobacter pylori (H pylori) eradication. However, different results are varied greatly and the availability of bismuth was limited in some countr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Di, Ke, Li, Ni, Zhen, Chen, Yu, Zhang, Lin-Hui, Zhu, Shao-Hua, Li, Chan-Juan, Shang, Lei, Liang, Jie, Shi, Yong-Quan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556219/ https://www.ncbi.nlm.nih.gov/pubmed/28796053 http://dx.doi.org/10.1097/MD.0000000000007697

Ejemplares similares

Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection: A 1-week, open-label, randomized trial
por: Su, Jing, et al.
Publicado: (2017)

Multiple Genetic Analysis System-Based Antibiotic Susceptibility Testing in Helicobacter pylori and High Eradication Rate With Phenotypic Resistance-Guided Quadruple Therapy
por: Dong, Fangyuan, et al.
Publicado: (2015)

Optimal treatment duration of bismuth-containing quadruple therapy in Helicobacter pylori infection: A retrospective study
por: Kim, Ji Yoon, et al.
Publicado: (2023)

A 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for Helicobacter pylori eradication: A single center experience
por: Abd-Elsalam, Sherief, et al.
Publicado: (2016)

The efficacy and safety of Clostridium butyricum and Bacillus coagulans in Helicobacter pylori eradication treatment: An open-label, single-arm pilot study
por: Zhang, Jian, et al.
Publicado: (2020)

A Randomized Control Trial Comparing 2 Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori Eradication
por: Chuah, Seng-Kee, et al.
Publicado: (2016)

Comparison of quadruple and triple Furazolidone containing regimens on eradication of helicobacter pylori
por: Mokhtare, Marjan, et al.
Publicado: (2015)

The influence of pretreatment with PPI on Helicobacter pylori eradication: A systematic review and meta-analysis
por: Kuang, Sheng, et al.
Publicado: (2021)

Effect of gastric microbiota on quadruple Helicobacter pylori eradication therapy containing bismuth
por: Niu, Zhan-Yue, et al.
Publicado: (2021)

Effects of Clarithromycin-Containing Quadruple Therapy on Helicobacter Pylori Eradication after Nitroimidazole-Containing Quadruple Therapy Failure
por: Fakheri, Hafez, et al.
Publicado: (2016)

The Efficacy of Berberine-Containing Quadruple Therapy on Helicobacter Pylori Eradication in China: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Hu, Qian, et al.
Publicado: (2020)

Tailored Therapy Versus Empiric Chosen Treatment for Helicobacter pylori Eradication: A Meta-Analysis
por: Chen, Han, et al.
Publicado: (2016)

Helicobacter pylori reinfection and its risk factors after initial eradication: A protocol for systematic review and meta-analysis
por: Li, Renliang, et al.
Publicado: (2021)

Characteristics and background mucosa status of early gastric cancer after Helicobacter pylori eradication: A narrative review
por: Wei, Yali, et al.
Publicado: (2022)

Efficacy and safety of triple therapy containing berberine hydrochloride, amoxicillin, and rabeprazole in the eradication of Helicobacter pylori
por: Chen, Xing Xing, et al.
Publicado: (2022)

Probiotics for Standard Triple Helicobacter pylori Eradication: A Randomized, Double-blind, Placebo-controlled Trial
por: Hauser, Goran, et al.
Publicado: (2015)

Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes
por: Kim, Sung Eun, et al.
Publicado: (2017)

Efficacy and safety of bismuth quadruple regimens containing tetracycline or furazolidone for initial eradication of Helicobacter pylori
por: Wang, Junxian, et al.
Publicado: (2021)

The efficacy and safety of different bismuth agents in Helicobacter pylori first-line eradication: A multicenter, randomized, controlled clinical trial
por: Cao, Yaping, et al.
Publicado: (2021)

Efficacy of Helicobacter pylori eradication therapy for treatment of functional dyspepsia: A protocol for systematic review and meta-analysis
por: Wang, Jue, et al.
Publicado: (2021)

Seven-day triple therapy is sufficient to eradicate infection caused by Helicobacter pylori without 23S rRNA point mutation
por: Lee, Jung Wook, et al.
Publicado: (2021)

Comparison of the Eradication Rate between 1- and 2-Week Bismuth-Containing Quadruple Rescue Therapies for Helicobacter pylori Eradication
por: Yoon, Jai Hoon, et al.
Publicado: (2012)

Tailored eradication vs empirical bismuth-containing quadruple therapy for first-line Helicobacter pylori eradication: A comparative, open trial
por: Choi, Youn I, et al.
Publicado: (2019)

Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
por: Gisbert, Javier P, et al.
Publicado: (2012)

Helicobacter pylori eradication may influence timing of endoscopic surveillance for gastric cancer in patients with gastric precancerous lesions: A retrospective study
por: Dore, Maria Pina, et al.
Publicado: (2018)

Comparative study of magnifying narrow-band imaging and conventional white light endoscopy in the diagnosis of Helicobacter pylori status after eradication therapy
por: Tahara, Tomomitsu, et al.
Publicado: (2019)

Evaluation of safety and pharmacokinetics of bismuth‐containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication
por: Huh, Ki Young, et al.
Publicado: (2021)

Multiple Bismuth Quadruple Therapy Containing Tetracyclines Combined with Other Antibiotics and Helicobacter pylori Eradication Therapy
por: Sun, Yingchao, et al.
Publicado: (2022)

Association Between Early Helicobacter pylori Eradication and a Lower Risk of Recurrent Complicated Peptic Ulcers in End-Stage Renal Disease Patients
por: Chang, Shen-Shong, et al.
Publicado: (2015)

Halitosis and helicobacter pylori infection: A meta-analysis
por: Dou, Wenhuan, et al.
Publicado: (2016)

Efficacy of a quadruple therapy regimen for Helicobacter pylori eradication after partial gastrectomy
por: Zhang, F., et al.
Publicado: (2016)

Clarithromycin versus Gemifloxacin in Quadruple Therapeutic Regimens for Helicobacter Pylori Infection Eradication
por: Mansour-Ghanaei, Fariborz, et al.
Publicado: (2017)

Which is the best choice for Helicobacter pylori eradication? Dual therapy or quadruple therapy?
por: Bacaksız, Elif Gram, et al.
Publicado: (2022)

Local Immune Response in Helicobacter pylori Infection
por: Kivrak Salim, Derya, et al.
Publicado: (2016)

Association between Helicobacter pylori infection and nonalcoholic fatty liver: A meta-analysis
por: Liu, Rongqiang, et al.
Publicado: (2019)

Association between Helicobacter pylori infection and colorectal polyps
por: Basmaci, Nergis, et al.
Publicado: (2023)

Helicobacter pylori prevalence in the Southwest of China: A protocol for systematic review
por: Wang, Rui, et al.
Publicado: (2020)

Biosynthesis, structure and biological function of cholesterol glucoside in Helicobacter pylori: A review
por: Zhang, Lanchi, et al.
Publicado: (2023)

Comparison of Azithromycin and Metronidazole in a Quadruple-Therapy Regimen for Helicobacter pylori Eradication in Dyspepsia
por: Agah, Shahram, et al.
Publicado: (2009)

Sequential Therapy vs Quadruple Therapy for Helicobacter pylori Eradication in South West of Iran
por: Masjedizadeh, Abdol Rahim, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3531pio5cgnk5bucj93cr4ti4i